Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

Market Cap	9.02B +72.7%
Revenue (ttm)	1.54B +14.6%
Net Income	174.25M -17.3%
EPS	1.00 -47.1%
Shares Out	173.73M
PE Ratio	51.72
Forward PE	n/a
Dividend	0.31 (0.59%)
Ex-Dividend Date	May 26, 2026

Volume	1,774,930
Open	51.92
Previous Close	51.91
Day's Range	50.66 - 52.37
52-Week Range	29.32 - 84.62
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sale of fine chemicals in China. It operates in four segments: Iodine Derivatives, Industrial Catalysts (precious metals), Organosilicon Series, and Chemiluminescent Materials. The company offers iodine derivatives, such as potassium iodide, sodium iodide, cesium iodide, potassium iodate, methyl iodide, diiodomethane, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldis...

• Industry: Industrial Inorganic Chemicals
• Founded: 2008
• Employees: 748
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301617

Financial Performance

In 2025, SHE:301617's revenue was 1.46 billion, an increase of 10.30% compared to the previous year's 1.33 billion. Earnings were 172.29 million, a decrease of -19.05%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 15, 2026

Data Sources Report a data error